Hope for Children with Autism: 80% Success Rate of Cannabis

09/08/2018 6 min read

Study: Medical Cannabis Helps 80% of Autistic Children

Autism is not simply a manageable condition for either those affected or their parents.

Scientific Advances in the Treatment of Autism Spectrum Disorder

Autism spectrum disorder represents one of the most complex challenges in the field of pediatric neurology. Families living with this condition face daily difficulties ranging from communication problems to severe episodes of anxiety. Over decades, conventional therapeutic options have shown significant limitations, leading parents and medical professionals to search for more effective alternatives.

In this context, medical cannabis has emerged as a promising therapeutic option. Recent research, particularly studies conducted at leading medical centers, increasingly documents results that exceed traditional expectations for treatment.

Clinical Research: Methodology and Participants

A groundbreaking study led by Dr. Adi Aran at Shaare Zedek Medical Center in Jerusalem has provided revealing data on the cannabinoid profile in the treatment of autism. Sixty children diagnosed with autism spectrum disorder participated in the study, receiving a cannabis extract with a specific composition over a seven-month period:

20% CBD (Cannabidiol) - the main non-psychoactive compound
1% THC (Tetrahydrocannabinol) - in minimal concentrations
Controlled administration using standardized extracts

This specific genetics was selected due to its optimized cannabinoid profile for neurological effects without significant psychoactive components.

Documented Clinical Results

The data collected after seven months of observation showed significant improvements in several developmental areas. The evaluations were based on detailed questionnaires completed by primary caregivers, focusing on three central areas:

Improvements in Behavior and Communication

80% of participants showed remarkable improvements in their overall condition. Specifically, 62% experienced significant changes in behavioral patterns, including a reduction in disruptive episodes and an improved ability for self-regulation.

Communication, traditionally one of the most challenging aspects of the autism spectrum, showed progress in 50% of the cases studied. These ranged from improved eye contact to an increase in spontaneous verbalization.

Reduction of Anxiety Symptoms

40% of families reported a notable decrease in the anxiety levels observed in their children. This figure is particularly remarkable considering that one third of participants showed no anxiety symptoms before the start of the study.

Safety and Tolerability Profile

One of the most notable aspects of the study was the observed safety profile. Unlike many conventional pharmacological treatments, the medical cannabis extracts showed exceptional tolerability in the pediatric population studied.

The terpenes contained in the formulations used, including myrcene with its characteristic calming properties, contributed to the overall therapeutic profile without causing significant side effects.

International Context of Research

Israel has positioned itself as a global leader in medical cannabis research, particularly in pediatric neurological applications. Israeli research centers have developed rigorous protocols that enable controlled studies with vulnerable populations while maintaining the highest ethical and scientific standards.

This specific study represents a milestone in understanding how different cannabinoid profiles can influence the neurological development and overall well-being of individuals with autism spectrum disorder.

Future Implications

The documented results open new avenues of research in the field of pediatric neurology. Medical cannabis genetics specifically developed for therapeutic applications are the subject of increasingly sophisticated studies.

The international scientific community is following these developments with great interest, as they represent a potential alternative to treatments that have historically shown limitations in efficacy and tolerability.

Considerations for Families and Healthcare Professionals

It is essential that any consideration of medical cannabis treatment takes place under specialized medical supervision. Each case within the autism spectrum presents unique characteristics that require individual assessment.

The extracts used in clinical studies differ significantly from unregulated commercial products. The standardization of cannabinoids and the purity of the formulations are crucial aspects for the safety and efficacy of treatment.

Research continues to advance, and additional publications are expected that will provide a deeper understanding of the mechanisms of action and the optimal applications of medical cannabis in the treatment of autism spectrum disorder.